Confirmation of HIFU Position in Expanding Focal Therapy Trend in Prostate Cancer
Strong Recognition of EDAP's Expertise in Lithotripsy Innovation
LYON, France, March 25, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported today positive feedback from participation in the 26 th Annual European Association of Urology (EAU) Conference, held in Vienna, Austria from March 18-21, 2011.The EAU conference is the world's premier urology event with more than 14,000 urologists in attendance. All urinary pathologies and related existing and new innovative therapies were addressed and discussed. A major topic at this year's meeting was the move to a focal approach in the treatment of prostate cancer. The change in prostate cancer patient profile to younger patients with a life expectancy of more than 15 years after diagnosis is irrevocably changing the treatment strategy and approach. This new generation of patients is not appropriate for radical surgery or other invasive alternatives, and not willing to accept a no treatment strategy. These patient trends are pushing the urology community to design a way of controlling the disease with a repeatable, multimodal and flexible technology. Ablatherm-HIFU meets these criteria and provides the most complete and adapted answer to the establishment of focal therapy. The conference also provided EDAP with the opportunity to showcase its latest successful innovation, the Sonolith i-move lithotripter. Urologists have shown strong interest for this equipment, particularly its revolutionary infrared stereo-vision system to localize urinary stones in real-time. Live demonstrations of all innovative features of our Sonolith i-move were performed continuously at the EDAP booth during the three days of the exhibition. The EDAP booth was the most active and probably the most visited booth in the exhibition area. In addition to the strong attendance and visits of our existing customers and partners, the Company recorded more than 100 lead sheets from new contacts and projects.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV